Results 261 to 270 of about 323,501 (341)

Upper extremity deep vein thrombosis associated with systemic lupus erythematosus and antiphospholipid syndrome

Journal of General and Family Medicine, EarlyView.
Masahiro Yabe, Nozomi Ozaki, Nobuhiro Sato, Norihito Nakamura, Azusa Aoyama, Shuichi Murakami, Yasuo Hirose   +6 more
wiley   +1 more source

Will biodiversity actions yield healthy places? A systematic review of human health outcomes associated with biodiversity‐focused urban greening

People and Nature, EarlyView.
Abstract There is growing interest in using urban greening projects to support biodiversity. While there are many potential co‐benefits, the health outcomes resulting from biodiversity‐supporting activities have yet to be synthesized. We conducted a systematic review of health outcomes associated with seven biodiversity‐supporting elements, including ...
Erica N. Spotswood, Myla Aronson, Micaela Bazo, Erin Beller, J. D. Brown, Iryna Dronova, Cesar O. Estien, Howard Frumkin, Joseph Galarraga, Robin Grossinger, Kim Hachadoorian, Brandon Herman, Thomas Jennings, Viniece Jennings, Ming Kuo, Robert I. McDonald, Daphne Miller, Alessandro Rigolon, Jennifer Symonds, Karen Weinbaum   +19 more
wiley   +1 more source

Pathogenesis of Autoimmunity/Systemic Lupus Erythematosus (SLE). [PDF]

Cells
Shiozawa S.
europepmc   +1 more source

A 15‐year population‐based study on incidence and vaccination coverage in pediatric inflammatory bowel disease in Italy

Pediatric Investigation, EarlyView.
Increasing incidence of pediatric inflammatory bowel disease (IBD) and suboptimal vaccination coverage in Apulia, Italy (2009–2023). A total of 1044 incident cases of paediatric IBD were identified in the period 2009–2023 in Apulia, Italy, giving an average annual standardized incidence rate of 12.7/100 000. A significant increase in incidence occurred
Francesca Fortunato, Angelo Campanozzi, Michele Di Toma, Alessandra Marinari, Domenico Martinelli   +4 more
wiley   +1 more source

Never say never

Journal of Hospital Medicine, EarlyView.
Gurpreet Dhaliwal, Jagmeet Dhingra, Tom Fraser, Leal Herlitz, James Pile   +4 more
wiley   +1 more source

Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy

Phytotherapy Research, EarlyView.
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee, Yu Jin So, Il‐Joo Jo, Ji Yong Jang, Tae Han Yook, Jun Ho Lee, Sung Wook Kim, Kangwook Lee, Soo Jung Park, Gabsik Yang   +9 more
wiley   +1 more source

Gut microbiota and metabolism in systemic lupus erythematosus: from dysbiosis to targeted interventions. [PDF]

Eur J Med Res
Zhu JH, Wu LP, Deng L, Zang SG, Li XB, Chen X, Yu JX.   +6 more
europepmc   +1 more source

STUDIES ON DNase I ACTIVITY AND ITS HEAT-LABILE INHIBITOR IN SYSTEMIC LUPUS ERYTHEMATOSUS

, 1973
Hirobumi Kondo
openalex   +2 more sources

Association of OAS1 rs1051042 polymorphism with genetic susceptibility and clinical phenotypes to systemic lupus erythematosus in a Chinese population

Rheumatology &Autoimmunity, EarlyView.
OAS1 is an interferon‐induced gene that has been reported to be associated with the susceptibility of some infectious diseases, but there is little data on OAS1 single nucleotide polymorphism (SNP) associated with Systemic lupus erythematosus (SLE).
Xin Huang, Ruifang Wu, Miao Yang, Qianwen Li, Shuaihantian Luo   +4 more
wiley   +1 more source